» Articles » PMID: 28574827

Induction of Immunoglobulin Transcription Factor 2 and Resistance to MEK Inhibitor in Melanoma Cells

Overview
Journal Oncotarget
Specialty Oncology
Date 2017 Jun 3
PMID 28574827
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Primary or acquired resistance to MEK inhibitors has been a barrier to successful treatment with MEK inhibitors in many tumors. In this study, we analyzed genome-wide gene expression profiling data from 6 sensitive and 6 resistant cell lines to identify candidate genes whose expression changes are associated with responses to a MEK inhibitor, selumetinib (AZD6244). Of 62 identified differentially expressed genes, we selected Immunoglobulin Transcription Factor 2, also known as transcription factor 4 as a potential drug resistance marker for further analysis. This was because the ITF-2 expression increase in resistant cell lines was relatively high and a previous study has suggested that ITF-2 functions as an oncogene in human colon cancers. We also established an AZD6244 resistant cell line (M14/AZD-3) from an AZD6244 sensitive M14 cell line. The expression of the ITF-2 was elevated both in primary AZD6244 resistant cell line, LOX-IMVI and acquired resistant cell line, M14/AZD-3. Targeted silencing of ITF-2 by siRNA significantly enhanced susceptibility to AZD6244 in resistant cells. Wnt/β-catenin pathway was activated through direct interaction of p-ERK and GSK3β. Our results suggest that up-regulation of the ITF-2 gene expression is associated with cellular resistance to MEK inhibitors, and activation of Wnt signaling pathway through interaction of p-ERK and GSK3β seems to be a mechanism for increase of ITF-2.

Citing Articles

UV-Induced Somatic Mutations Driving Clonal Evolution in Healthy Skin, Nevus, and Cutaneous Melanoma.

Loras A, Gil-Barrachina M, Marques-Torrejon M, Perez-Pastor G, Martinez-Cadenas C Life (Basel). 2022; 12(9).

PMID: 36143375 PMC: 9503451. DOI: 10.3390/life12091339.


Extract (Pc-Ex) Containing Emodin Suppresses Lung Cancer-Induced Cachexia by Suppressing TCF4/TWIST1 Complex-Induced PTHrP Expression.

Fang X, Kim Y, Lee Y, Lee M, Lim W, Yim W Nutrients. 2022; 14(7).

PMID: 35406121 PMC: 9002362. DOI: 10.3390/nu14071508.


Resistance to Molecularly Targeted Therapies in Melanoma.

Patel M, Eckburg A, Gantiwala S, Hart Z, Dein J, Lam K Cancers (Basel). 2021; 13(5).

PMID: 33807778 PMC: 7961479. DOI: 10.3390/cancers13051115.


Integrated bioinformatics analysis of the crucial candidate genes and pathways associated with glucocorticoid resistance in acute lymphoblastic leukemia.

Chen Y, Jiang P, Wen J, Wu Z, Li J, Chen Y Cancer Med. 2020; 9(8):2918-2929.

PMID: 32096603 PMC: 7163086. DOI: 10.1002/cam4.2934.


Role of miR-214 in regulation of β-catenin and the malignant phenotype of melanoma.

Prabhakar K, Rodriguez C, Jayanthy A, Mikheil D, Bhasker A, Perera R Mol Carcinog. 2019; 58(11):1974-1984.

PMID: 31338875 PMC: 6800786. DOI: 10.1002/mc.23089.


References
1.
Holt S, Logie A, Odedra R, Heier A, Heaton S, Alferez D . The MEK1/2 inhibitor, selumetinib (AZD6244; ARRY-142886), enhances anti-tumour efficacy when combined with conventional chemotherapeutic agents in human tumour xenograft models. Br J Cancer. 2012; 106(5):858-66. PMC: 3305954. DOI: 10.1038/bjc.2012.8. View

2.
Dai B, Meng J, Peyton M, Girard L, Bornmann W, Ji L . STAT3 mediates resistance to MEK inhibitor through microRNA miR-17. Cancer Res. 2011; 71(10):3658-68. PMC: 3392199. DOI: 10.1158/0008-5472.CAN-10-3647. View

3.
Huynh H, Chow P, Soo K . AZD6244 and doxorubicin induce growth suppression and apoptosis in mouse models of hepatocellular carcinoma. Mol Cancer Ther. 2007; 6(9):2468-76. DOI: 10.1158/1535-7163.MCT-07-0162. View

4.
Davies B, Logie A, McKay J, Martin P, Steele S, Jenkins R . AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action in vivo, pharmacokinetic/pharmacodynamic relationship, and potential for combination in.... Mol Cancer Ther. 2007; 6(8):2209-19. DOI: 10.1158/1535-7163.MCT-07-0231. View

5.
Yoon S, Seger R . The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors. 2006; 24(1):21-44. DOI: 10.1080/02699050500284218. View